AB0857 CERTOLIZUMAB PEGOL RELOADING SUCCESSFULLY CONTROLS INFLAMMATORY ARTHRITIS FLARES DURING PREGNANCY – A CASE REPORT

Background: Approximately 50% of patients with inflammatory arthritis (IA) experience worsening of disease activity during pregnancy.1,2 Given the evidence that increased disease activity immediately before or during pregnancy is associated with adverse pregnancy outcomes, it is imperative to maintain tighter disease control during this period.3 Treatment options are limited to steroids or disease-modifying anti-rheumatic drugs (DMARDs) …